MSD’s truth about the Januvia agreement breakdown
Since the consigned pharmaceutical company of ‘Januvia(generic name: sitagliptin),’ a DPP-4 inhibitor recording KRW 150 billion annual sales with its single and complex drugs, was recently changed, severe fluctuation occurred.
Through <Doctors News> on the 18th, MSD Korea unveiled opposition to...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
